Shin-ichiro Kubo

Kanagawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Association Between a 1-Year Group-Based Telerehabilitation Program and the Quality of Life of People With Parkinson's Disease: An Observational Study.

Association Between a 1-Year Group-Based Telerehabilitation Program and the Quality of Life of People With Parkinson's Disease: An Observational Study.

Journal: Archives of physical medicine and rehabilitation

Published: September 08, 2025

Satisfaction, effectiveness, and usability of telerehabilitation for Parkinson's disease patients.

Satisfaction, effectiveness, and usability of telerehabilitation for Parkinson's disease patients.

Journal: Journal of rehabilitation medicine

Published: January 14, 2024

Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's disease.

Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 30, 2023

The effects of lactulose on constipation in patients with Parkinson's disease: An exploratory pilot study.

The effects of lactulose on constipation in patients with Parkinson's disease: An exploratory pilot study.

Journal: eNeurologicalSci

Published: February 22, 2023

The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients

The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients

Journal: Rinsho shinkeigaku = Clinical neurology

Published: December 20, 2021

Parkinson's disease with a typical clinical course of 17 years overlapped by Creutzfeldt-Jakob disease: an autopsy case report.

Parkinson's disease with a typical clinical course of 17 years overlapped by Creutzfeldt-Jakob disease: an autopsy case report.

Journal: BMC neurology

Published: September 02, 2021

What can we learn from the effect of trihexyphenidyl on motor fluctuations during continuous levodopa-carbidopa intestinal gel infusion (LCIG)? - First documented case.

What can we learn from the effect of trihexyphenidyl on motor fluctuations during continuous levodopa-carbidopa intestinal gel infusion (LCIG)? - First documented case.

Journal: Clinical parkinsonism & related disorders

Published: June 16, 2020

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 25, 2019

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Journal: Brain : a journal of neurology

Published: November 12, 2018

Anhedonia and its correlation with clinical aspects in Parkinson's disease.

Anhedonia and its correlation with clinical aspects in Parkinson's disease.

Journal: Journal of the neurological sciences

Published: April 16, 2016

Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipids.

Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipids.

Journal: Expert opinion on therapeutic targets

Published: November 27, 2015

A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease: A Repeat Dose and Pharmacokinetic Study.

A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease: A Repeat Dose and Pharmacokinetic Study.

Journal: Clinical neuropharmacology

Published: November 05, 2015

Showing 1-12 of 25

Last Updated: 09/26/2026